Acetylsalicylic acid Recruiting Phase 2 Trials for Acute Ischemic Stroke (AIS) / Transient Ischaemic Attack (TIA) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03766581Oral Factor XIa Inhibitor for the Prevention of New Ischemic Stroke in Patients Receiving Aspirin and Clopidogrel Following Acute Ischemic Stroke or Transient Ischemic Attack (TIA)